Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-α

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 2, 2004, Pages 225-231

  Laurenzi, L ^a   Natoli, S ^a   Di Filippo, F ^a   Calamaro, A ^a   Centulio, F ^a   Anza M ^a   Cavaliere, F ^a   Marcelli, M E ^a   Garinei, R ^a   Arcuri, Edoardo ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hyperthermic limb perfusion; Systemic Inflammatory Response Syndrome (S.I.R.S.); Tumor Necrosis Factor

Indexed keywords

CARBON MONOXIDE; HEMOGLOBIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERY CATHETER; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TOXICITY; CARDIOTOXICITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; FEMALE; HEMODYNAMICS; HUMAN; HYPOXIA; INTENSIVE CARE UNIT; LIMB PERFUSION; LOW DRUG DOSE; LUNG EDEMA; LUNG HEMODYNAMICS; LUNG TOXICITY; MALE; MELANOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; RADIAL ARTERY; RECURRENT CANCER; RESPIRATORY FAILURE; SARCOMA; SEPSIS; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RESPIRATORY TRACT DISEASES; SARCOMA; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242662663     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Eggermont A.M., van Geel A.N., de Wiet J.H., ten Hagen T.L.: The role of isolated limb perfusion for melanoma confined to the extremities, Surg. Clin. North. Am. 83: 371-384, 2003.
2. Scheadt J., Crowley R., Miller D., Kavanah M.: Isolated limb perfusion: a literature review. J. Extra Corpor. Technol. 34: 140-143, 2002.
3. Tracey K.S., Bentler B., Lowry S.F.: Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986.
4. Damas P.: The cytokines a possible role in sepsis. Curr. Opin. Anaesth. 4: 241-246, 1991.
5. Thijs L.G., Hack L.E.: Time course of cytokine levels in sepsis. Int. Care Med. 21,2 S 258, 1995.
6. Mollay R.G., Mannik J.A., Rodrick M.L.: Cytokines, sepsis and immunomodulation. Br. J. Surg. 80: 289-297, 1993.
7. Lamy M., Deby-Dupont: In sepsis a mediator inhibitor mismatch. Int. Care Med. 21,2: S 250-257, 1995.
8. Bentler B., Milsark I.W., Cerami A.C.: Passive immunization against cachectin tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229: 869-871, 1985.
9. Tracey K.L., Fong Y., Hesse D.G.: Anti-cachectin TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conferences: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864-874, 1992.
11. Salvo I., De Cian W., Musicco M., Langer M., Piadena R., Walfler A., Montani C., Magni E., the SEPSIS Study Group: The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, SEPSIS, severe sepsis and septic shock. Int. Care Med. 21, 2: 5244-5249, 1995.
12. Di Filippo F., Calabrò A., Giannarelli D., Carlini S., Cavaliere F., Moscarelli F., Cavaliere R.: Prognostic variables in recurrent limb melanoma treated with antiblastic perfusion. Cancer 63: 2551-2561, 1989.
13. Lejeune F.S., Lienard D., Eggermont A., Schraffordt Koops H., Gerain S., Rosenkaimer F., Schunitz P.: Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced experience melanoma. Circulatory Shock 43: 191-197, 1994.
14. ILP in De Vita Cancer: Principles and practice of Oncology. 15Th eds. J. Clin. Oncol. 14: 479, 1996.
15. Eggimann P., Chiolero R., Chassot P.G., Lienard D., Gerain S., Lejeune F.: Systemic and haemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest 107, 4: 1074-1082, 1995.
16. Goris S. A., Bakhorst P.A., Nuytinck S.K.S., Gimbere S.S.F.: Multiple Organ Failure. Generalized Autodestructive Inflammation? Arch. Surg. 120: 1109-1116, 1985.
17. Calandra T., Baumgartner S.D., Gran G.E., Wu M.M., Lambert P.H., Schellekens J., Verhoef J., Glauser M.P.: Prognostic values of tumor necrosis factor: cachectin, interleukin-1, interferon, in the serum of patients with septic shock. S. Infect. Dis. 161: 982-981, 1990.
18. Offner F., Philippe S., Vogelaers D., Colardyn F., Baele G., Baudrihaye M., Vermeulen A., Leroux-Roels G.: Serum Tumor necrosis factor levels in patients with infections disease and septic shock. S. Lab. Clin. Med. 116: 100-105, 1990.